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In May 2003, an outbreak of fatal hemorrhagic fever,
caused by yellow fever virus, occurred in southern Sudan.
Phylogenetic analysis showed that the virus belonged to
the East African genotype, which supports the contention
that yellow fever is endemic in East Africa with the potential
to cause large outbreaks in humans. 
Y
ellow fever virus (genus Flavivirus, family
Flaviviridae) is a mosquitoborne virus endemic in
tropical regions of Africa and South America, where it has
been responsible for large epidemics. The virus is main-
tained in sylvatic transmission cycles involving nonhuman
primates but uses humans as the sole vertebrate host in
urban epidemics. In South America, the sylvatic vectors
belong to the Haemogogus and Sabethes genera, and the
urban vector is Aedes aegypti; in Africa, Aedes species
mosquitoes serve as both sylvatic and urban vectors. The
virus causes febrile disease with necrotic hepatitis in
humans, and death rates can exceed 50%. Although an
effective vaccine is available, the virus remains a major
public health threat, particularly in Africa, where vaccina-
tion is limited by poverty, civil wars, and the inaccessibil-
ity of rural areas where outbreaks of the disease occur. The
World Health Organization estimates 200,000 cases of the
disease occur annually and 30,000 deaths, but because of
underreporting, only a small percentage of these cases are
recorded.
The first genetic studies of yellow fever virus identified
three topotypes, which corresponded with the virus’s geo-
graphic distribution in West Africa, Central and East
Africa, and South America (1). In a more recent study,
which included a larger number of isolates, greater diver-
sity was identified in Africa, with five genotypes designat-
ed: Central/East Africa, East Africa, Angola, West Africa I,
and West Africa II (2). We report the genetic characteriza-
tion of yellow fever virus isolates from an outbreak of the
disease in southern Sudan in 2003.
The Study 
During the first week of May 2003, the Early Warning
and Response Network, established in 1999 in southern
Sudan, reported an outbreak of fatal hemorrhagic fever of
unknown etiology in the Imatong region of Torit County,
which is near the Ugandan border, in a mountainous area
covered with tropical rain forest. During the civil unrest in
early 2002, many residents were relocated to an internally
displaced persons camp in Ikotos County, but in 2003, a
number of the residents moved back to the Imatong region.
During April and May 2003 suspected cases of hemorrhag-
ic illness were reported, and blood samples collected from
Sarianga, Itohom, Lenyleny, Tarafafa, Lofi, and Locomo
villages were tested at the Kenya Medical Research
Institute (KEMRI), in Nairobi, where yellow fever virus
was identified as the causative agent of the outbreak.
Aliquots of specimens were submitted to the Special
Pathogens Unit at the National Institute for Communicable
Diseases in Johannesburg for confirmation of the diagno-
sis. A report dated June 19, 2003, from the Office of the
United Nations Resident and Humanitarian Coordinator
for the Sudan described a steady decline in the number of
cases occurring during the 4 weeks before the report with
a total of 162 suspected cases with 48 deaths in Torit
County. However, the report also noted that the recording
of suspected cases was inadequate, the figures quoted were
an estimate, and final case numbers and deaths were uncer-
tain. The details of the outbreak and laboratory investiga-
tions are reported in a separate publication.
Virus isolates were obtained from three patients, two
from Locomo village and one from Lofi village. The viral
isolations were performed by injecting serum samples
from all the patients into suckling mice. RNA was extract-
ed from harvested mouse brain tissue by using Trizol
reagent (Gibco BRL, Life Technologies, Gaithersburg,
MD), according to the manufacturer’s directions. A670-bp
region of the polyprotein gene, which included the 3′ end
of the premembrane protein gene, the complete membrane
protein gene, and the 5′ end of the envelope protein gene,
was amplified by using reverse transcription–polymerase
chain reaction (RT-PCR) (2). The nucleotide sequence for
each amplicon was determined by using Big Dye
Terminator Sequencing Ready Reaction kits with
AmpliTaq DNA polymerase FS, as described by the sup-
plier (Applied Biosystems, Warrington, UK). A consensus
sequence was established by aligning the sequences
obtained from the Sudan 2003 outbreak of yellow fever
with sequences obtained from GenBank for yellow fever
isolates from previous outbreaks of the virus in Africa
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Alignment of the nucleotide sequence data was per-
formed by using DNASIS for Windows version 2.5
(Hitachi Software Engineering America, San Francisco,
CA). The phylogenetic analysis was performed on a 572-
bp region of the amplicons by using a weighted maximum
parsimony method, transversion:transition weighting of
5:1, and Phylogenetic Analysis Using Parsimony (PAUP)
software version 4.0b4a for Macintosh (3). Bootstrap con-
fidence intervals were calculated from 100 heuristic search
replicates. The tree (Figure) shows that the virus circulat-
ing during the recent outbreak in southern Sudan was
closely related to an isolate from an outbreak in Kenya in
1993 that belonged to the East African genotype. Sequence
divergence was determined by using Molecular
Evolutionary Genetics Analysis (MEGA) version 2.1 (4) to
calculate the average p-distances or the proportion of pair-
wise differences within and between groups. The recent
Sudan isolates clustered with the East African isolates. A
pairwise comparison of nucleotide sequences within the
group showed an average distance of 0.111 and 0.179
between the Sudan isolates and an isolate from Kenya
(1993) and isolates from Uganda (1948), respectively. No
insertions or deletions were found in the Sudan nucleotide
sequences compared with the reference strains; however, a
number of nucleotide substitutions occurred, most of
which were synonymous, and a pairwise comparison of the
predicted amino acid sequences showed a high degree of
homology. The predicted amino acid sequences were iden-
tical for the Kenyan and the Sudan isolates, while the p-
distance calculated between the Sudan and Ugandan
isolates from 1948 was 0.016. The nucleotide heterogene-
ity between isolates from East and Central Africa
(1.6%–11.6%) supports the concept that different geno-
types are circulating and that outbreaks are not the result of
imported virus from urban areas (2).
Conclusions
Outbreaks of yellow fever virus have frequently been
reported from areas within West Africa since the 18th cen-
tury, with far fewer outbreaks being identified in East
Africa. Serologic evidence for the presence of yellow fever
virus in Sudan, Kenya, Uganda, and Tanzania was first
reported in 1936 (5). However, not until 1940 was the first
epidemic confirmed in East Africa, in central Sudan (5).
Sporadic cases were identified annually in East Africa until
1959, when an outbreak was recorded in the Blue Nile
region of Sudan and subsequently in the neighboring
region of Ethiopia (6). From 1960 to 1962, the largest out-
break to date in Africa occurred in southwest Ethiopia.
Additional serologic studies confirmed that yellow fever
activity was widespread in Uganda, Somalia, Ethiopia, and
Kenya (6). Although two possible cases of yellow fever in
Kenya were reported in 1943 (7), not until 1992–1993 was
a large outbreak confirmed in the Rift Valley province of
Kenya (7,8). Subsequent sporadic isolations of virus have
been made in East Africa since then, but no large epi-
demics were recognized until the outbreak in southern
Sudan in 2003. Originally, researchers speculated that out-
breaks in East Africa were less frequent and smaller than
the large outbreaks recorded in West Africa because they
were the result of virus’s being introduced into the area at
the time of the outbreak. However, the genetic data suggest
that yellow fever virus is endemic in East and Central
Africa, with outbreaks occurring as a result of favorable
environmental conditions (2). The fact that the isolates
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Table. History of yellow fever isolates included in the study 
Strain Origin  Year  Source  GenBank  no. 
SPU160/03/23 Sudan  2003  Human  AY690831 
SPU160/03/24 Sudan  2003  Human  AY690832 
SPU160/03/25 Sudan  2003  Human  AY690833 
14FA Angola  1971  Human  AF369669 
HD 38564  Burkina Faso  1983  Human  AF369670 
Serie 227  Ethiopia  1961  Human  AF369674 
85-82H Ivory  Coast  1982  Human  U54798 
BC 7914  Kenya  1993  Human  AF369676 
IB AR 45244  Nigeria  1969  Mosquito  AF369677 
H117491 Nigeria  1987  Human  AF369682 
Rendu Senegal  1953  Human  U89338 
M 90-5  Sudan  1940  Human  AF369692 
M 112-4  Sudan  1940  Human  AF369693 
A 709-4-A2  Uganda  1948  Human  AF369694 
MR 896  Uganda  1948  Human  U52422 
SE 7445  Uganda  1964  Human  AF369695 
LSF 4  Zaire  1958  Human  AF369697 
SH1464 Senegal  1965  Human  AF369688 from Sudan were closely related to an isolate obtained 10
years ago in Kenya supports the contention that yellow
fever is endemic in East Africa and has the potential to
cause large outbreaks when conditions favor transmission
to humans. 
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Figure. Phylogenetic tree showing the relationship between yellow
fever virus circulating during the outbreak in southern Sudan in
2003 and other isolates from previous outbreaks in Africa, deter-
mined by using a 572-bp region of the genome, a weighted parsi-
mony method and Phylogenetic Analysis Using Parsimony (PAUP)
software. Node values indicate bootstrap confidence values gen-
erated from 100 replicates (heuristic search).
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